-
Winter 2012/2013vol 02 | issue 04
Julia Wiley, Tony Handler, Michael B. Lawing, Lori Petitti -
Survivor Profile
Touched by an AngelJonny Imerman is the heart and hub of a network of cancer survivors.
by Pamela Ferdinand
-
Yesterday & Today
A Leading LadyBetty Ford's candor about her breast cancer diagnosis helped bring a private issue out of the shadows.
by Corinna Wu
-
Fall 2012vol 02 | issue 03
Pamela Clark, Emily-Kate Niskey, Loretta Cox, Tim Buckland -
Survivor Profile
Spreading the WordAn African-American banking pioneer finds fulfillment in increasing prostate cancer awareness.
by Yvonne Lee
-
The Survival GapIn the Nowhere Land between adult and pediatric cancer treatment, young adults face survival rates that have missed out on the gains seen by other age groups. Can new efforts help them improve their outcomes?
by Charlotte Huff
-
Yesterday & Today
A Touch of MagicElizabeth Montgomery led a bewitching life that was cut short by colorectal cancer in 1995.
by Sue Rochman
-
Summer 2012vol 02 | issue 02
Evelyn Reyes, Sarah Dees, Greg Cantwell, Patrick Gavin. -
Yesterday & Today
Alec Guinness, Reluctant Intergalactic IconLiver cancer took the legendary actor and his wife of 62 years just months apart. Twelve years later, where do efforts to prevent and treat the disease stand?
by Jocelyn Selim
-
Spring 2012vol 02 | issue 01
Todd Spurrier, Barry Haigis, Marianthy Karantzes, Rebecca Casciato
Legislation to speed cancer drug development for children and adolescents requires drug companies to test drugs in children, but trials in people under 18 may take years to generate results.
by Marci A. Landsmann
Understanding Stress and CancerA symposium at the AACR Annual Meeting explores how social factors contribute to elevated risk of cancer in some populations.
by Eric Fitzsimmons
Exploring Amino Acids’ Impact on Tumor GrowthResearchers are investigating how to match specific dietary changes with therapy to impede cancer progression.
by Thomas Celona
Study Shows Minority Participation in Clinical Trials May Be DecliningResearcher speculates that costly genetic testing may be limiting outreach to underserved communities.
by Marci A. Landsmann
-
Using Lymphocytes to Attack TumorsSooner rather than later may be the best strategy for using an experimental treatment for advanced melanoma.
-
Closing Disparities Through Genetic TestingOlufunmilayo Olopade seeks widespread use of testing to encourage prevention and early detection of deadly cancers.
Learning Medicare’s ABCDs
